SCLX Stock Analysis: Buy, Sell, or Hold?
SCLX - Scilex Holding Company Common Stock
$8.52
-0.17 (-1.96%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 13, 2026
13d
Get Alerted When SCLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SCLX is down 22.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SCLX is down 22.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$19.61
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$12.18
30.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SCLX is currently trading at $8.52, which is considered oversold relative to its 30-day fair value range of $10.24 to $13.62. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.8) compared to its historical average (4.5). Remarkably, the market is currently pricing in an annual earnings decline of 14.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SCLX is in a strong downtrend. Immediate support is located at $8.24, while resistance sits at $12.29.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $490.00 (+5538.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SCLX is in a strong downtrend. Immediate support is located at $8.24, while resistance sits at $12.29.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $490.00 (+5538.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$10.24 -
$13.62
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding SCLX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 5538.7% below Wall St target ($490.00)
- WARNING: Recommendation downgraded due to -22.5% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$10.24 -
$13.62
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$8.25
Resistance Level
$12.30
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
2.79
Wall Street Target
$490.00
(+5538.7%)
Revenue Growth (YoY)
-26.9%
Valuation Discount vs History
-14.8% cheaper
PE vs Historical
2.8 vs 4.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.8%
(market-implied from PE analysis)
1-Year Target
$7.82
(-10%)
2-Year Target
$7.04
(-19%)
3-Year Target
$6.34
(-27%)
3-Yr Target (if PE normalizes)
(PE: 3→5)
$10.20
(+17%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.8 to 4.5
Stabilization Target:
$14.00
(+61.0%)
PE Expansion Potential:
+61.0%
Last updated: January 30, 2026 4:03 PM ET
Data refreshes hourly during market hours. Next update: 5:03 PM
Data refreshes hourly during market hours. Next update: 5:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1111 | 60 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$135 | 63 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$332 | 66 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$245 | 61 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$192 | 58 HOLD |
Advanced SCLX Option Strategies
Professional options setups generated by AI based on today's SCLX price and gamma walls.
